0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Autism - Epidemiology Forecast to 2028
Published Date: March 2019
|
Report Code: DELV-Epid-329
Home | Market Reports | Health | Health Conditions | Neurological Conditions
Autism Epidemiology Forecast to 2028

Autism - Epidemiology Forecast to 2028

Code: DELV-Epid-329
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Autism - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Autism epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Autism Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Autism in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Autism outlook. It also includes the explanation of changing trends of epidemiology outlining the Autism scenario.

Autism Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Autism thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Autism explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Autism Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Autism

Key assessments
• Patient Segmentation in Autism
• Autism Risk & Burden
• Factors driving growth in a specific Autism patient population

1. Report Introduction
2. Autism Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Autism in 2016
2.2. Patient Share Distribution of Autism in 2028
3. Disease Background and Overview: Autism
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Autism in 7MM
4.3. Total Prevalent/ Incident Patient Population of Autism in 7MM – By Countries
5. Epidemiology of Autism by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Autism
5.1.3. Sub-Type Specific cases of the Autism *
5.1.4. Sex- Specific Cases of the Autism *
5.1.5. Diagnosed Cases of the Autism
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Autism
5.4.3. Sub-Type Specific cases of the Autism *
5.4.4. Sex- Specific Cases of the Autism *
5.4.5. Diagnosed Cases of the Autism
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Autism
5.5.3. Sub-Type Specific cases of the Autism *
5.5.4. Sex- Specific Cases of the Autism *
5.5.5. Diagnosed Cases of the Autism
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Autism
5.6.3. Sub-Type Specific cases of the Autism *
5.6.4. Sex- Specific Cases of the Autism *
5.6.5. Diagnosed Cases of the Autism
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Autism
5.7.3. Sub-Type Specific cases of the Autism *
5.7.4. Sex- Specific Cases of the Autism *
5.7.5. Diagnosed Cases of the Autism
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Autism
5.8.3. Sub-Type Specific cases of the Autism *
5.8.4. Sex- Specific Cases of the Autism *
5.8.5. Diagnosed Cases of the Autism
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Autism
5.9.3. Sub-Type Specific cases of the Autism *
5.9.4. Sex- Specific Cases of the Autism *
5.9.5. Diagnosed Cases of the Autism
6. Unmet Needs of the Autism
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

LSIT OF TABLES :

Table 1: Total Prevalent/Incident Cases of the Autism in 7MM
Table 2: Total Prevalent/Incident Cases of the Autism in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Autism in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Autism in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Autism in United States (2016-2028)*
Table 6: Diagnosed Cases of the Autism in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Autism in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Autism in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Autism in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Autism in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Autism in France (2016-2028)
Table 12: Sub-Type Specific cases of the Autism in France (2016-2028) *
Table 13: Sex- Specific Cases of the Autism in France (2016-2028) *
Table 14: Diagnosed Cases of the Autism in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Autism in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Autism in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Autism in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Autism in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Autism in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Autism in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Autism in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Autism in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Autism in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Autism in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Autism in UK (2016-2028) *
Table 26: Diagnosed Cases of the Autism in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Autism in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Autism in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Autism in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Autism in Japan (2016-2028)

LIST OF FIGURES :

Figure 1: Total Prevalent/Incident Cases of the Autism in 7MM
Figure 2: Total Prevalent/Incident Cases of the Autism in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Autism in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Autism in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Autism in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Autism in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Autism in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Autism in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Autism in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Autism in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Autism in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Autism in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Autism in France (2016-2028) *
Figure 14: Diagnosed Cases of the Autism in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Autism in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Autism in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Autism in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Autism in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Autism in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Autism in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Autism in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Autism in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Autism in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Autism in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Autism in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Autism in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Autism in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Autism in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Autism in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Autism in Japan (2016-2028)

REPORTS VIEWED RECENTLY

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global and United States Neurodegenerative Disease Market Size Status and Forecast 2021 2027
Global and United States Neurodegenerative Disease Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-16X6731
Sat Sep 04 00:00:00 UTC 2021

Add to Cart

Global and United States Neurodegenerative Drugs Market Insights Forecast to 2027
Global and United States Neurodegenerative Drugs Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-26D6533
Sat Sep 04 00:00:00 UTC 2021

Add to Cart

Global and Japan Tardive Dyskinesia TD Treatment Market Size Status and Forecast 2021 2027
Global and Japan Tardive Dyskinesia (TD) Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-17C6770
Sat Sep 04 00:00:00 UTC 2021

Add to Cart

Global Lambert Eaton Myasthenic Syndrome LEMS Therapeutics Sales Market Report 2021
Global Lambert-Eaton Myasthenic Syndrome (LEMS) Therapeutics Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-26B6155
Fri Aug 13 00:00:00 UTC 2021

Add to Cart